Topoisomerase I inhibitors: selectivity and cellular resistance - Archive ouverte HAL Access content directly
Journal Articles Drug Resistance Updates Year : 1999

Topoisomerase I inhibitors: selectivity and cellular resistance

(1) , (2) , , ,
Yoshimasa Urasaki
  • Function : Author
Jiaxi Wu
  • Function : Author
Gary Laco
  • Function : Author


Topoisomerase I (top1) inhibitors (camptothecins and other structurally diverse compounds) are effective and promising anticancer agents. Determinants of selectivity toward cancer cells and resistance are multifactorial. These factors can be separated in three groups. The first is related to alterations in drug distribution and metabolism. The second group includes both quantitative and qualitative (mutations) differences in top I. The third group includes resistance and sensitivity factors downstream from the cleavage complexes. They include DNA repair, cell cycle checkpoints and apoptosis, and are probably key to the relative selectivity of camptothecins toward cancer cells and to clinical resistance. Copyright 1999 Harcourt Publishers Ltd.

Dates and versions

inserm-02438282 , version 1 (14-01-2020)



Yves Pommier, Philippe Pourquier, Yoshimasa Urasaki, Jiaxi Wu, Gary Laco. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Updates, 1999, 2 (5), pp.307-318. ⟨10.1054/drup.1999.0102⟩. ⟨inserm-02438282⟩
32 View
0 Download



Gmail Facebook Twitter LinkedIn More